J. Zeuthen

发表

Escape mechanisms in tumor immunity: a year 2000 update.

G. Pawelec, S. Heinzel, R. Kiessling, 2000, Critical reviews in oncogenesis.

Primary cutaneous B‐cell lymphoma: a clinical, histological, phenotypic and genotypic study of 21 cases

P. Guldberg, K. Grønbæk, J. Zeuthen, 2000, The British journal of dermatology.

Gene in Lymphoid Malignancies MMAC1/PTEN Alterations of the

P. Guldberg, K. Grønbæk, J. Zeuthen, 2011 .

Characterization of a human ovarian teratocarcinoma‐derived cell line

P. Avner, J. Zeuthen, B. Giovanella, 1980, International journal of cancer.

Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity.

J. Bartek, J. Lukas, P. Guldberg, 2000, Experimental cell research.

Alterations of the MMAC1/PTEN gene in lymphoid malignancies.

P. Guldberg, J. Zeuthen, K. Hou‐Jensen, 1998, Blood.

Intravesical BCG therapy in bladder carcinoma. Effect on cytotoxicity, IL-2 production and phenotype of peripheral blood mononuclear cells.

J. Zeuthen, G. Hermann, K. Steven, 1991, Scandinavian journal of urology and nephrology.

Expression of immunoglobulin synthesis in human myeloma x non-lymphoid cell heterokaryons: evidence for negative control.

J. Zeuthen, K. Nilsson, S. Stenman, 1976, Cell differentiation.

Monoclonal antibody against a lactose epitope of glycosphingolipids binds to melanoma tumour cells

J. Zeuthen, S. Teneberg, K. Karlsson, 1993, Glycoconjugate Journal.

Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.

P. Guldberg, J. Zeuthen, P. thor Straten, 1997, Cancer research.

Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma.

J. Becker, E. Bröcker, J. Zeuthen, 2000, The Journal of investigative dermatology.

The immunogenic properties of human melanomas and melanoma-associated antigens recognized by cytotoxic T lymphocytes.

J. Zeuthen, K. Dzhandzhugazyan, A. Kirkin, 1998, Bratislavske lekarske listy.

A Human Melanoma Cell Line, Recognized by Both HLA Class I and Class II Restricted T Cells, is Capable of Initiating both Primary and Secondary Immune Responses

J. Zeuthen, G. Gaudernack, A. Kirkin, 1995, Scandinavian journal of immunology.

Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL.

T. Elliott, J. Neefjes, J. Zeuthen, 1999, Journal of immunology.

Transfection of glioma cells with the neural‐cell adhesion molecule NCAM: Effect on glioma‐cell invasion and growth in vivo

E. Bock, R. Bjerkvig, J. Zeuthen, 1994, International journal of cancer.

Ecto‐ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomas

J. Zeuthen, P. thor Straten, K. Dzhandzhugazyan, 1998, FEBS letters.

In vivo and in vitro generation of a new altered HLA phenotype in melanoma‐tumour‐cell variants expressing a single HLA‐class‐I allele

J. Zeuthen, F. Garrido, L. Real, 1998, International journal of cancer.

Two-site time-resolved immunofluorometric assay of human insulin.

J. Zeuthen, J. Marniemi, T. Lövgren, 1986, Clinical chemistry.

Gastrin releasing peptide GRP(14–27) in human breast cancer cells and in small cell lung cancer

J. Zeuthen, L. Nedergaard, A. Vangsted, 1991, Breast Cancer Research and Treatment.

B CELL ACTIVATION

M. Leptin, J. Zeuthen, F. Melchers, 1983 .

Regulation of B lymphocyte replication and maturation

M. Leptin, J. Zeuthen, F. Melchers, 1982, Journal of cellular biochemistry.

Deficiency of malic enzyme: a possible marker for malignancy in lymphoid cells

S. Povey, J. Zeuthen, S. Jeremiah, 1981, Annals of human genetics.

Heterokaryons in the analysis of genes and gene regulation

J. Zeuthen, 1975, Humangenetik.

Reactivation of chick erythrocyte nuclei after fusion with enucleated cells

N. Ringertz, J. Zeuthen, T. Ege, 1975, Somatic cell genetics.

An assay for peptide binding to HLA-Cw*0102.

T. Elliott, J. Zeuthen, J. Haurum, 1999, Tissue antigens.

IgE production in vitro by two rat myeloma tumor lines (IR2 and IR162).

J. Vuust, J. Zeuthen, H. Bennich, 1980, Cell differentiation.

The Role of Endogenous Peptides in the Direct Pathway of Alloreactivity to Human MHC Class II Molecules Expressed on CHO Cells

G. Pawelec, J. Zeuthen, H. Kalbacher, 1996, Immunological reviews.

B-Cell and Epstein-Barr Virus (EBV) Associated Functions in Human Cells and Hybrids

J. Zeuthen, G. Klein, 1980 .

Somatic cell hybrids between human lymphoma lines. III. Surface markers

G. Klein, J. Zeuthen, A. Rosén, 1977, International journal of cancer.

Detection of circulating tumor lysate–reactive CD4+ T cells in melanoma patients

C. C. Fleischer, J. Zeuthen, M. Petersen, 2004, Cancer Immunology, Immunotherapy.

Accumulation of identical T cells in melanoma and vitiligo-like leukoderma.

J. Becker, P. Guldberg, E. Bröcker, 1999, The Journal of investigative dermatology.

In situ T cell responses against melanoma comprise high numbers of locally expanded T cell clonotypes.

J. Becker, P. Guldberg, J. Zeuthen, 1999, Journal of immunology.

Expanded T Cell Clonotypes Comprise High Numbers of Locally In Situ T Cell Responses Against Melanoma

Hansen, J. Becker, P. Guldberg, 1999 .

Human-human hybridomas and human monoclonal antibodies obtained by fusion of lymph node lymphocytes from breast cancer patients.

B. Rasmussen, J. Zeuthen, C. Rose, 1988, Cancer research.

Expression of transporter associated with antigen processing 1 and 2 (TAP1/2) in malignant melanoma cell lines

J. Zeuthen, P. thor Straten, T. Seremet, 1997, International journal of cancer.

Epstein-Barr virus (EBV), lymphocytes and transformation

J. Zeuthen, 2004, Journal of Cancer Research and Clinical Oncology.

Aberrant p27Kip1 promoter methylation in malignant melanoma

J. Bartek, J. Bártková, P. Guldberg, 2000, Oncogene.

Strain‐ and age‐dependent natural and activated in vitro cytotoxicity in athymic nude mice

J. Zeuthen, A. Vangsted, M. Schou, 1994, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Amino Acid Substitutions in the Melanoma Antigen Recognized by T Cell 1 Peptide Modulate Cytokine Responses in Melanoma-Specific T Cells

C. Geisler, J. Zeuthen, N. Odum, 2000, Journal of immunotherapy.

Establishment of gp100 and MART-1/Melan-A-specific cytotoxic T lymphocyte clones using in vitro immunization against preselected highly immunogenic melanoma cell clones

J. Zeuthen, P. thor Straten, K. Dzhandzhugazyan, 1999, Cancer Immunology, Immunotherapy.

Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient

J. Zeuthen, F. Garrido, L. Real, 2001, Cancer Immunology, Immunotherapy.

Interleukin-2 gene therapy of residual EL-4 leukaemia potentiates the effect of cyclophosphamide pretreatment

J. Zeuthen, J. Bubeník, J. Šímová, 2005, Journal of Cancer Research and Clinical Oncology.

Cells and cytokines in immunotherapy and gene therapy of cancer.

R. Rees, G. Pawelec, R. Kiessling, 1999, Critical reviews in oncogenesis.

Differential modulation by interferon γ of the sensitivity of human melanoma cells to cytolytic T cell clones that recognize differentiation or progression antigens

J. Zeuthen, P. thor Straten, A. Kirkin, 1996, Cancer Immunology, Immunotherapy.

Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma.

J. Becker, E. Bröcker, J. Zeuthen, 1996, The Journal of clinical investigation.

Enzyme-linked immunosorbent assay for human urokinase-type plasminogen activator and its proenzyme using a combination of monoclonal and polyclonal antibodies.

J. Zeuthen, K. Danø, P. Andreasen, 1986, Journal of immunoassay.

Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: a genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb

P. Guldberg, K. Grønbæk, N. E. Hansen, 1998, Leukemia.

Induction of HLA expression in Daudi cells after cell fusion

J. Dausset, G. Klein, J. Zeuthen, 1977, Immunogenetics.

HLA antigen expression at the single cell level on a K562 × B cell hybrid: An analysis with monoclonal antibodies using bacterial binding assays

P. Wernet, J. Zeuthen, A. Ziegler, 1982, Somatic cell genetics.

From Peasants to Social Assistance Recipients? Semi-forced Urbanization in China

J. Zeuthen, 2020, Social Welfare in India and China.

Escape from host-antitumor immunity.

G. Pawelec, R. Kiessling, J. Zeuthen, 1997, Critical reviews in oncogenesis.

Immunochemical determination of acetylcholinesterase in amniotic fluid--an evaluation of eleven monoclonal antibodies.

B. No̸rgaard-Pedersen, J. Zeuthen, O. Bjerrum, 1987, Clinica chimica acta; international journal of clinical chemistry.

Somatic cell hybrids between human lymphoma lines. IV. Establishment and characterization of a p3HR‐1/daudi hybrid

G. Klein, S. Povey, J. Zeuthen, 1978, International journal of cancer.

Influenza virus-specific murine T cell hybridomas which recognize virus hemagglutinin in conjunction with H-2d and display helper functions for B cells.

J. Zeuthen, F. Melchers, W. Gerhard, 1982, Current topics in microbiology and immunology.

clone recognizing a wild-type p53-derived peptide Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte

L. Fugger, C. Melief, P. Guldberg, 1996 .

In vivo eradication of an established human melanoma by an in vitro generated autologous cytotoxic T cell clone: A SCID use model

J. Zeuthen, A. Kirkin, A. Stenholm, 1998, International journal of cancer.

Characterization of monoclonal antibodies against bovine insulin.

J. Zeuthen, L. Heding, V. Kruse, 1986, Annales de l'Institut Pasteur. Immunologie.

A comparison of flow cytometry and immunohistochemistry in human colorectal cancers

J. Jensenius, J. Zeuthen, O. Nielsen, 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Immortalizing human T-cell function.

J. Zeuthen, B. Malissen, 1982, Immunology today.

T-cell receptor clonotype mapping using denaturing gradient gel electrophoresis : analysis of clonal T-cell responses in melanoma.

J. Becker, P. Guldberg, J. Zeuthen, 2001, Methods in molecular medicine.

Nonsense suppressors of Saccharomyces cerevisiae can be generated by mutation of the tyrosine tRNA anticodon

P. Piper, J. Zeuthen, F. Sherman, 1976, Nature.

Structural abnormalities in chromosome 15 in cell lines with reduced expression of beta-2 microglobulin

J. Zeuthen, E. Klein, A. Rosén, 1977, Immunogenetics.

Some recent trends in studies of human lymphoid cells: B-cells, Epstein-Barr virus, and transformation.

J. Zeuthen, G. Klein, 1981, Haematology and blood transfusion.

Double immunoglobulin production in cloned somatic cell hybrids between two human lymphoid cell lines

G. Klein, J. Zeuthen, A. Rosén, 1977, Cell.

Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle in a new set of somatic cell hybrids.

J. Zeuthen, G. Klein, G. Clements, 1977, Cancer letters.

The selection of somatic cell hybrids between human lymphoma cell lines

G. Klein, S. Povey, J. Zeuthen, 1976, Somatic cell genetics.

Somatic cell hybrids between human lymphoma lines. II. Spontaneous and induced patterns of the Epstein‐Barr virus (EBV) cycle

G. Klein, J. Zeuthen, G. Clements, 1976, International journal of cancer.

Generation of human monoclonal antibodies against ganglioside antigens and their applications in the diagnosis and therapy of cancer.

J. Zeuthen, M. Alfonso, 1996, Acta oncologica.

Rescaling China’s rural–urban frontier: Exception as norm in the access to development

J. Zeuthen, 2020 .

Replication of the F'lac sex factor in the cell cycle of Escherichia coli

J. Zeuthen, M. Pato, 2004, Molecular and General Genetics MGG.

Distribution of the Burkitt's lymphoma-associated antigen (BLA) in normal human tissue and malignant lymphoma as defined by immunohistological staining with monoclonal antibody 38.13

J. Zeuthen, G. Pallesen, 2004, Journal of Cancer Research and Clinical Oncology.

Inducibility of the Epstein‐Barr virus (EBV) cycle and surface marker properties of ebv‐negative lymphoma lines and their in vitro EBV‐converted sublines

G. Klein, J. Zeuthen, M. Jondal, 1976, International journal of cancer.

A "Panreactive" T cell hybridoma which produces TCGF constitutively.

J. Zeuthen, F. Melchers, C. Corbel, 1982, Current topics in microbiology and immunology.

Mutational analysis of oncogenes and tumor suppressor genes in human cancer using denaturing gradient gel electrophoresis.

P. Guldberg, J. Zeuthen, P. thor Straten, 2002, Methods in molecular medicine.

Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin.

J. Zeuthen, A. Vaheri, E. Salonen, 1985, The Journal of biological chemistry.

Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody.

J. Zeuthen, K. Danø, E. Wilson, 1982, Biochemistry.

Applications of immunoperoxidase techniques in specificity testing of monoclonal antibodies (Mabs) against von Willebrand factor (vWf).

J. Zeuthen, J. Ingerslev, A. Bukh, 1988, Clinica chimica acta; international journal of clinical chemistry.

Immunochemical detection of a small cell lung cancer-associated ganglioside (FucGM1) antigen in serum.

S. Hakomori, J. Zeuthen, A. Vangsted, 1991, Cancer research.

Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies.

P. Guldberg, J. Zeuthen, K. Hou‐Jensen, 2000, The Journal of investigative dermatology.

The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.

J. Bartek, J. Lukas, J. Bártková, 1996, Cancer research.

T cell-independent B cell response to self-monosialogangliosides: primary response monoclonal antibodies.

J. Zeuthen, L. E. Fernández, M. E. Lanio, 1995, Hybridoma.

Inactive proenzyme to tissue‐type plasminogen activator from human melanoma cells, identified after affinity purification with a monoclonal antibody.

J. Zeuthen, K. Danø, R. Stephens, 1984, The EMBO journal.

Phase I study of single, escalating doses of a superantigen-antibody fusion protein (PNU-214565) in patients with advanced colorectal or pancreatic carcinoma.

H. Hansen, J. Zeuthen, S. E. Nielsen, 2000, Journal of immunotherapy.

A T-helper cell x Molt4 human hybridoma constitutively producing B-cell stimulatory and inhibitory factors.

J. Zeuthen, C. Lindqvist, B. Kallin, 1986, Lymphokine research.

Monoclonal Antibodies and Their Radionuclide Conjugates: Practical and Regulatory Aspects

J. Zeuthen, 1987 .

Plasminogen activating enzyme in cultured glioblastoma cells. An immunofluorescence study with monoclonal antibody.

J. Zeuthen, K. Danø, E. Dabelsteen, 1982, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Monoclonal antibodies to K88ab, K88ac and K88ad fimbriae from enterotoxigenic Escherichia coli.

J. Zeuthen, S. E. Jorsal, P. Klemm, 1986, Microbial pathogenesis.

Human teratocarcinoma cell lines. A review.

J. Zeuthen, 1981, International journal of andrology.

Serum immunoassay of a small cell lung cancer associated ganglioside: development of a sensitive scintillation proximity assay

H. Wallin, J. Zeuthen, A. Vangsted, 1992, Glycoconjugate Journal.

Higher-order structure of human mitotic chromosomes.

F. Crick, J. Zeuthen, A. L. Bak, 1977, Proceedings of the National Academy of Sciences of the United States of America.

Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia

Peter Ralph, J. Zeuthen, E. Klein, 1976, International journal of cancer.

Concurrent disruption of p16INK4a and the ARF-p53 pathway predicts poor prognosis in aggressive non-Hodgkin's lymphoma

P. Guldberg, K. Grønbæk, J. Zeuthen, 2000, Leukemia.

Reduced LAK cytotoxicity of peripheral blood mononuclear cells in patients with bladder cancer: Decreased LAK cytotoxicity caused by a low incidence of CD56+ and CD57+ mononuclear blood cells

J. Zeuthen, G. Hermann, K. Steven, 1990, Journal of Clinical Immunology.

Isolation of novel HLA-DR restricted potential tumor-associated antigens from the melanoma cell line FM3.

G. Pawelec, J. Zeuthen, H. Kalbacher, 1997, Cancer research.

Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity.

P. Guldberg, K. Grønbæk, N. E. Hansen, 1998, Blood.

Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma

P. Guldberg, J. Zeuthen, P. Straten, 1999, Oncogene.

LEADING ARTICLE Concurrent disruption of p16 INK4a and the ARF-p53 pathway predicts poor prognosis in aggressive non-Hodgkin's lymphoma

P. Guldberg, J. Zeuthen, T. Nedergaard, 2000 .

Detection of mutations in GC-rich DNA by bisulphite denaturing gradient gel electrophoresis.

P. Guldberg, J. Zeuthen, A. Platz, 1998, Nucleic acids research.

Simultaneous presence of translocations t(14;18) and t(2;8) in a case of chronic lymphocytic leukemia.

C. Geisler, T. Plesner, J. Zeuthen, 1986, Cancer genetics and cytogenetics.

Cancer/Testis Antigens: Structural and Immunobiological Properties

J. Zeuthen, K. Dzhandzhugazyan, A. Kirkin, 2002, Cancer investigation.

Expression of sv40 t antigen during the cell cycle of SV40‐transformed cells

N. Ringertz, J. Zeuthen, S. Stenman, 1975, International journal of cancer.

Single‐step DGGE‐based mutation scanning of the p53 gene: Application to genetic diagnosis of colorectal cancer

H. Nielsen, P. Guldberg, J. Zeuthen, 1997, Human mutation.

Transfer of tRNAs to somatic cells mediated by Sendai-virus-induced fusion.

P. Piper, J. Zeuthen, J. Celis, 1976, Proceedings of the National Academy of Sciences of the United States of America.

Transformation induced by Epstein-Barr virus and the role of the nuclear antigen.

J. Zeuthen, G. Klein, J. Luka, 1980, Cold Spring Harbor symposia on quantitative biology.

Immunological Relationship Between the Fast-Acting Plasminogen Activator Inhibitors from Plasma, Blood Platelets and Endothelial Cells Demonstrated with a Monoclonal Antibody Against an Inhibitor from Placenta

J. Zeuthen, S. Thorsen, J. Selmer, 1986, Thrombosis and Haemostasis.

Tumour-specific MHC-class-II-restricted responses after in vitro sensitization to synthetic peptides corresponding to gp100 and Annexin II eluted from melanoma cells

Thomas Halder, G. Pawelec, S. Heinzel, 1998, Cancer Immunology, Immunotherapy.

Presentation of Cytosolic Glycosylated Peptides by Human Class I Major Histocompatibility Complex Molecules in Vivo

T. Elliott, J. Neefjes, J. Zeuthen, 1999, The Journal of experimental medicine.

The end of urban–rural differentiation in China?: Hukou and resettlement in Chengdu’s urban–rural integration: Jesper W. Zeuthen and Michael B. Griffiths

J. Zeuthen, Michael B. Griffiths, 2012 .

Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules.

T. Elliott, J. Zeuthen, T Elliott, 2000, Tissue antigens.

Higher order structure of mitotic chromosomes.

J. Zeuthen, A. L. Bak, 1978, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

Monoclonal antibody that specifically inhibits a human Mr 52,000 plasminogen-activating enzyme.

J. Zeuthen, K. Danø, K. Kaltoft, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Plasminogen Activator Inhibitor-1 Is the Primary Inhibitor of Tissue-Type Plasminogen Activator in Pregnancy Plasma

J. Zeuthen, S. Thorsen, J. Selmer, 1987, Thrombosis and Haemostasis.

Tumor infiltrating lymphocytes in melanoma comprise high numbers of T-cell clonotypes that are lost during in vitro culture.

J. Becker, P. Guldberg, J. Zeuthen, 2000, Clinical immunology.

Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells

J. Hjelmborg, J. Zeuthen, C. Fenger, 2003, Cancer Immunology, Immunotherapy.

Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody

J. Zeuthen, P. Klasse, T. Bugge, 1990, Journal of virology.

The V410I (G1228A) variant of the caspase-10 gene is a common polymorphism of the Danish population.

J. Zeuthen, E. Ralfkiaer, K. Grønbaek, 2000, Blood.

Recombinant interleukin-2 and lymphokine-activated killer cell treatment of advanced bladder cancer: clinical results and immunological effects.

J. Zeuthen, G. Hermann, K. Steven, 1992, Cancer research.

Identification of an Epstein‐Barr virus‐coded thymidine kinase.

J. Zeuthen, K. Powell, J. Arrand, 1986, The EMBO journal.

Complex forms of mitochondrial DNA in human B cells transformed by Epstein-Barr virus (EBV)

J. Zeuthen, G. Christiansen, C. Christiansen, 2004, Journal of Cancer Research and Clinical Oncology.

Preferential usage of T‐cell receptor αβ variable regions among tumor‐infiltrating lymphocytes in primary human malignant melanomas

J. Schøller, J. Zeuthen, K. Hou‐Jensen, 2007 .

In situ T cells in melanoma

J. Becker, P. Guldberg, J. Zeuthen, 1999, Cancer Immunology, Immunotherapy.

Blood group ABO-related glycosylation of urothelial cell lines: immunocytological, enzymatic, and genetic characterization.

E. Bennett, J. Zeuthen, H. Clausen, 1994, Cancer research.

Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide.

L. Fugger, C. Melief, P. Guldberg, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Immunohistochemical characterisation of the local immune response in azoxymethane‐induced colon tumours in the BDIX inbred rat strain

J. Ritskes-Hoitinga, J. Zeuthen, M. Kobaek-Larsen, 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Complete scanning of the CDK4 gene by denaturing gradient gel electrophoresis: A novel missense mutation but low overall frequency of mutations in sporadic metastatic malignant melanoma

P. Guldberg, K. Grønbæk, J. Zeuthen, 1997, International journal of cancer.

Pattern of Replication of a Colicin Factor During the Cell Cycle of Escherichia coli

J. Zeuthen, M. Pato, E. Morozow, 1972, Journal of bacteriology.

Evidence for a folded structure of human chromosomes.

J. Zeuthen, A. L. Bak, 2009, Hereditas.

Detection and Characterization of αβ-T-Cell Clonality by Denaturing Gradient Gel Electrophoresis (DGGE)

P. Guldberg, J. Zeuthen, I. Saeterdal, 1998 .

Peptides spanning the junctional region of both the abl/bcr and the bcr/abl fusion proteins bind common HLA class I molecules

L. Fugger, J. Zeuthen, M. Andersen, 2000, Leukemia.

Melanoma‐associated antigens recognized by cytotoxic T lymphocytes

J. Zeuthen, K. Dzhandzhugazyan, A. Kirkin, 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

The Immunogenic Properties of Melanoma-Associated Antigens Recognized by Cytotoxic T Lymphocytes

J. Zeuthen, K. Dzhandzhugazyan, A. Kirkin, 1998, Experimental and Clinical Immunogenetics.

Characterisation of tumour infiltrating lymphocytes and correlations with immunological surface molecules in colorectal cancer.

J. Zeuthen, A. Diederichsen, T. Kristensen, 1999, European journal of cancer.

Detection and characterization of alpha-beta-T-cell clonality by denaturing gradient gel electrophoresis (DGGE).

P. Guldberg, J. Zeuthen, I. Saeterdal, 1998, BioTechniques.

Sticky and smelly issues: lessons on tumour cell and leucocyte trafficking, gene and immunotherapy of cancer.

D. Taub, R. Vile, J. Zeuthen, 1998, British Journal of Cancer.

Expression of basic fibroblast growth factor and vascular endothelial growth factor in primary and metastatic melanoma from the same patients.

J. Zeuthen, K. Hou‐Jensen, A. Birck, 1999, Melanoma research.

Hybrids between human cell lines belonging to different hematopoietic pathways: analysis of HLA and myeloid surface antigens.

P. Wernet, J. Zeuthen, B. Uchánska‐Ziegler, 1983, Haematology and blood transfusion.

Characterization of human chromosomal unit fibers

J. Zeuthen, A. L. Bak, P. Bak, 1979, Chromosoma.

Higher levels of organization in chromosomes.

J. Zeuthen, A. L. Bak, P. Bak, 1979, Journal of theoretical biology.

Immunisation of colorectal cancer patients with autologous tumour cells.

J. Jensenius, O. Kronborg, J. Zeuthen, 1998, Oncology reports.

Recognition of human tumours: cancer/testis antigens

J. Zeuthen, K. Dzhandzhugazyan, A. Kirkin, 2001 .

Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. I. Isolation, characterization, cell surface markers, and B-cell markers.

S. Povey, J. Zeuthen, P. Ralph, 1982, Journal of the National Cancer Institute.

Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1).

S. Povey, J. Zeuthen, G. Klein, 1980, Journal of the National Cancer Institute.

Analysis of T cell receptor αβ variability in lymphocytes infiltrating melanoma primary tumours and metastatic lesions

J. Schøller, J. Zeuthen, K. Drzewiecki, 1994, Cancer Immunology, Immunotherapy.

Monoclonal antibodies for diagnosis and potential therapy of small cell lung cancer--the ganglioside antigen fucosyl-GM1.

J. Zeuthen, A. Vangsted, 1993, Acta oncologica.

Recognition of insulin on MHC-class-II-expressing L929 cells by antibody and T cells.

J. Zeuthen, B. Malissen, B. Rubin, 1989, Research in immunology.

Gene therapy of cancer: use of IL-2 gene transfer and kinetics of local T and NK cell subsets.

J. Zeuthen, J. Bubeník, J. Šímová, 1993, Anticancer research.

Recognition of human tumours: melanoma differentiation antigens

J. Zeuthen, A. Kirkin, 2001 .

Generation of human-melanoma-specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell lines

J. Zeuthen, P. Straten, Li Li, 1995, Cancer Immunology, Immunotherapy.

Interleukin-2 dose, blood monocyte and CD25+ lymphocyte counts as predictors of clinical response to interleukin-2 therapy in patients with renal cell carcinoma

J. Zeuthen, G. Hermann, P. Geertsen, 2005, Cancer Immunology, Immunotherapy.

Activation of preexisting T cell clones by targeted interleukin 2 therapy.

J. Becker, P. Guldberg, J. Zeuthen, 1998, Proceedings of the National Academy of Sciences of the United States of America.

In vitro production of TNF-α, IL-1β and IL-6 by mononuclear blood cells of patients with renal cell carcinoma undergoing rIL-2 treatment. Relation between clinical response and TNF-α production

J. Zeuthen, G. Hermann, M. Claesson, 1992 .

Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns.

I. Ernberg, J. Zeuthen, G. Klein, 1982, Journal of the National Cancer Institute.

Utilization of interleukin-2 gene transfer in local immunotherapy of cancer

J. Zeuthen, J. Bubeník, J. Šímová, 2005, Journal of Cancer Research and Clinical Oncology.

Lectin purified human class I MHC-derived peptides: evidence for presentation of glycopeptides in vivo.

H. Rammensee, S. Stevanović, T. Elliott, 2000, Tissue antigens.

Replication and expression in mammalian cells of transfected DNA; description of an improved erythrocyte ghost fusion technique.

J. Zeuthen, P. Sunnerhagen, G. Bjursell, 1983, Nucleic acids research.

Promises of Hope or Threats of Domination: Chinese mining in Greenland

J. Zeuthen, Malayna Raftopoulos, 2018 .

A stable TCGF-producing T cell hybridoma and its thioguanine-resistant variant suitable as a tool for the construction of new functional T hybridomas.

J. Zeuthen, F. Melchers, J. Andersson, 1982, Current topics in microbiology and immunology.

Chromosome banding and compaction

J. Zeuthen, A. L. Bak, A. L. Jørgensen, 2004, Human Genetics.

Monoclonal antibody to human 66,000 molecular weight plasminogen activator from melanoma cells. Specific enzyme inhibition and one‐step affinity purification.

J. Zeuthen, K. Danø, P. Andreasen, 1983, The EMBO journal.

A one‐step DGGE scanning method for detection of mutations in the K‐, N‐, and H‐ras oncogenes: Mutations at codons 12, 13 and 61 are rare in B‐cell non‐Hodgkin's lymphoma

P. Guldberg, J. Zeuthen, T. Nedergaard, 1997, International Journal of Cancer.

Higher-order structure of mitotic chromosomes.

J. Zeuthen, A. L. Bak, 1978, Cold Spring Harbor Symposia on Quantitative Biology.

Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines.

J. Zeuthen, C. Borrebaeck, M. Ohlin, 1993, Human antibodies and hybridomas.

Hybridization of a human myeloma permanent cell line with mouse cells.

J. Zeuthen, K. Nilsson, 1976, Cell differentiation.

Flow cytometric investigation of immune‐response‐related surface molecules on human colorectal cancers

J. Jensenius, O. Kronborg, J. Zeuthen, 1998, International journal of cancer.

Bittersweet China: New Discourses of Hardship and Social Organisation

J. Zeuthen, Michael B. Griffiths, 2014 .

[Interleukin-2 based immunotherapy of cancer].

J. Zeuthen, G. Hermann, K. Steven, 1990, Ugeskrift for laeger.

Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas.

J. Zeuthen, K. Hou‐Jensen, P. thor Straten, 1994, International journal of cancer.

Whose urban development? Changing credibilities, forms and functions of urbanization in Chengdu, China

J. Zeuthen, Jesper Zeuthen, 2017, Land Use Policy.

China’s rural urbanization and the state: Putting the countryside first?

J. Zeuthen, Elena Meyer-Clement, 2020 .

Analysis of T cell receptor alpha beta variability in lymphocytes infiltrating melanoma primary tumours and metastatic lesions.

J. Schøller, J. Zeuthen, K. Drzewiecki, 1994, Cancer immunology, immunotherapy : CII.

Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas.

J. Schøller, J. Zeuthen, K. Hou‐Jensen, 1994, International journal of cancer.

Chromosomal unit fibers in Drosophila

J. Zeuthen, P. Bak, A. Bak, 1979, Chromosoma.

Cytotoxicity and proliferation of splenocytes and lymph node cells from adjuvant‐treated nude mice:

J. Zeuthen, J. Rygaard, M. Schou, 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Assembly of the T-cell antigen receptor. Participation of the CD3 omega chain.

C. Geisler, J. Zeuthen, A. Vangsted, 1993, Journal of immunology.

Comparative delineation of T cell clonotypes in coexisting syngeneic B16 melanoma

J. Becker, P. Guldberg, J. Zeuthen, 2000, Cancer Immunology, Immunotherapy.

Induction of CD3δεω) by phorbol 12‐myristate 13‐acetate

H. Wallin, C. Geisler, J. Zeuthen, 1993 .

Expression of SV40 T antigen during inhibition of DNA synthesis.

J. Zeuthen, S. Stenman, 1976, Cancer letters.

Rule through Difference on China's Urban–Rural Boundary

J. Zeuthen, 2012 .

Single‐step DGGE‐based mutation scanning of the p53 gene: Application to genetic diagnosis of colorectal cancer

H. Nielsen, P. Guldberg, J. Zeuthen, 1997, Human mutation.

Sticky and smelly issues: lessons on tumour cell and leucocyte trafficking, gene and immunotherapy of cancer.

J. Zeuthen, Rg Vile, Ab Alexandroff, 1998, British Journal of Cancer.

Biosynthesis of the beta and beta' subunits of RNA polymerase in Escherichia coli.

J. Zeuthen, H. Matzura, B. Hansen, 1973, Journal of molecular biology.